Publication:
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure

Simple item page
dc.contributor.authorÇAVUŞOĞLU, YÜKSEL
dc.contributor.authorMERT, KADİR UĞUR
dc.contributor.authorNadir, AYDIN
dc.contributor.authorMUTLU, FEZAN
dc.contributor.authorMorrad, Bektas
dc.contributor.authorULUS, TANER
dc.contributor.institutionauthorNADİR, AYDIN
dc.date.accessioned2021-09-24T20:59:31Z
dc.date.available2021-09-24T20:59:31Z
dc.date.issued2015-09-01T00:00:00Z
dc.description.abstractBackground Ivabradine is a heart rate (HR)-lowering agent acting by inhibiting the I-f-channel. Dobutamine does increase the HR and has some deleterious effects on myocardium. So, we aimed to evaluate whether ivabradine treatment blunts a dobutamine-induced increase in HR.
dc.identifier.citationÇAVUŞOĞLU Y., MERT K. U. , Nadir A., MUTLU F., Morrad B., ULUS T., -Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure-, JOURNAL OF CARDIOVASCULAR MEDICINE, cilt.16, sa.9, ss.603-609, 2015
dc.identifier.doi10.2459/jcm.0000000000000033
dc.identifier.scopus84942824119
dc.identifier.urihttp://hdl.handle.net/20.500.12645/29518
dc.identifier.wosWOS:000369709200004
dc.titleIvabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure
dc.typeArticle
dspace.entity.typePublication
local.avesis.ide41ff4b6-ed64-478c-8279-88203b28112f
local.publication.isinternational1
relation.isAuthorOfPublication3c85f09a-5f63-4d46-8e50-ebab96bf25ed
relation.isAuthorOfPublication.latestForDiscovery3c85f09a-5f63-4d46-8e50-ebab96bf25ed
Files
Collections
Silinecekler